Suchergebnisse - "Deenen, Maarten J"

PubPharm (103)

1

A Nomogram to Predict Severe Toxicity in DPYD Wild-Type Patients Treated With Capecitabine-Based Anticancer Regimens

enthalten in: Clinical pharmacology and therapeutics | 2024

von Knikman, J. | Lopez-Yurda, M. | Meulendijks, D. | +5

2

A Nomogram to Predict Severe Toxicity in DPYD Wild‐Type Patients Treated With Capecitabine‐Based Anticancer Regimens

enthalten in: Clinical Pharmacology & Therapeutics | 2024

von Knikman, J. | Lopez‐Yurda, M. | Meulendijks, D. | +5

3

Identification of Medication-Related Risks in Bariatric Surgery Patients by Performing Structured Medication Reviews

enthalten in: Obesity surgery | 2023

von Böhm, D. | Berghuis, K. | Said, M. | +3

4

Identification of Medication-Related Risks in Bariatric Surgery Patients by Performing Structured Medication Reviews

enthalten in: Obesity surgery | 2023

von Böhm, D. | Berghuis, K. | Said, M. | +3

5

Dutch pharmacogenetics working group (DPWG) guideline for the gene-drug interaction between UGT1A1 and irinotecan

enthalten in: European journal of human genetics : EJHG | 2023

von Hulshof, E. | Deenen, M. | Nijenhuis, M. | +13

CommentIn: Eur J Hum Genet. 2023 Feb 8;:. - PMID 36750665

6

Correction : Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between UGT1A1 and irinotecan

enthalten in: European journal of human genetics : EJHG | 2023

von Hulshof, E. | Deenen, M. | Nijenhuis, M. | +13

ErratumFor: Eur J Hum Genet. 2023 Sep;31(9):982-987. - PMID 36443464

7

UGT1A1 genotype-guided dosing of irinotecan : time to prioritize patient safety

enthalten in: Pharmacogenomics | 2023

von Peeters, S. | Deenen, M. | Thijs, A. | +5

8

A Systematic Evaluation of Cost-Saving Dosing Regimens for Therapeutic Antibodies and Antibody-Drug Conjugates for the Treatment of Lung Cancer

enthalten in: Targeted oncology | 2023

von Ter Heine, R. | van den Heuvel, M. | Piet, B. | +17

9

A Systematic Evaluation of Cost-Saving Dosing Regimens for Therapeutic Antibodies and Antibody-Drug Conjugates for the Treatment of Lung Cancer

enthalten in: Targeted oncology | 2023

von ter Heine, R. | van den Heuvel, M. | Piet, B. | +17

10

The Effect of Genotyping on the Number of Pharmacotherapeutic Gene-Drug Interventions in Chronic Kidney Disease Patients

enthalten in: Pharmacy (Basel, Switzerland) | 2023

von Kerskes, C. | van den Eijnde, C. | Aarnoudse, A. | +3

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[11]